Symptom Guide

Menopause & Perimenopause Symptoms

What you're experiencing is real — and far more manageable than you may have been led to believe.

Perimenopause and menopause bring a wide range of physical and emotional changes driven by shifting hormone levels. Hot flashes, sleep disruption, brain fog, mood changes, and vaginal dryness are among the most common — and most treatable — symptoms in women's health.

At Haven OBGYN, menopause care is a clinical priority. We take a comprehensive, evidence-based approach informed by the latest guidelines from ACOG and the North American Menopause Society (NAMS).

Perimenopause vs. Menopause

These are two distinct — but connected — phases, each with its own characteristics and clinical considerations.

Perimenopause

The transitional phase leading up to menopause. Hormone levels — particularly estrogen and progesterone — begin to fluctuate unpredictably. Periods may become irregular, heavier, lighter, or less frequent. Can begin 2–10 years before the final period, typically starting in the mid-40s.

Menopause

Defined as 12 consecutive months without a menstrual period, marking the end of ovarian follicular activity. The median age of natural menopause in the U.S. is 51.3 years. Menopause before age 40 is termed premature ovarian insufficiency and requires specific evaluation.

Postmenopause

The years following the final period. Estrogen levels remain persistently low. Long-term health considerations include bone density loss, cardiovascular risk, and metabolic changes. Any bleeding after menopause is abnormal and always warrants prompt evaluation.

Common Symptoms — By Category

Menopause affects nearly every system in the body. Recognizing the full range of symptoms helps ensure nothing is missed or misattributed.

Vasomotor Symptoms

Affect approximately 75–80% of women. May begin during perimenopause and persist for years.

  • Hot flashes — sudden waves of heat, flushing, and sweating
  • Night sweats — hot flashes during sleep, often disrupting rest
  • Chills following hot flashes
  • Heart palpitations associated with vasomotor episodes
Cognitive & Mood

Frequently reported but often overlooked in clinical evaluations.

  • Brain fog — difficulty with memory, focus, and word retrieval
  • Mood changes — irritability, anxiety, low mood
  • Sleep disturbance — difficulty falling or staying asleep
  • Fatigue unrelated to sleep quality
Genitourinary (GSM)

Genitourinary Syndrome of Menopause — unlike vasomotor symptoms, tends to worsen over time without treatment.

  • Vaginal dryness, burning, or irritation
  • Pain during sex (dyspareunia)
  • Urinary urgency, frequency, or recurrent UTIs
  • Vaginal spotting or discharge
Physical & Metabolic

Estrogen decline affects metabolism, bone, muscle, and cardiovascular function.

  • Joint aches and muscle pain
  • Changes in body composition — increased abdominal fat
  • Decreased bone density (accelerated in first 2–3 years post-menopause)
  • Changes in cholesterol and cardiovascular risk profile
  • Skin thinning, dryness, and hair changes

When to Seek Evaluation

Hot flashes or night sweats significantly disrupting sleep or daily life
Irregular, heavy, or unusually light periods in your 40s
Symptoms of depression, anxiety, or significant mood changes new in midlife
Vaginal dryness or pain with sex affecting quality of life or relationships
Questions about hormone therapy — benefits, risks, and whether you're a candidate
Any bleeding after menopause (12+ months without a period) is abnormal and requires prompt evaluation — it is not a return of your period.

Dr. Mishra's Approach

Evidence-based menopause care — tailored to you

"The conversation around menopause has changed dramatically in the last decade. The 2023 NAMS hormone therapy position statement and updated ACOG guidance confirm what many clinicians have known: for the right patient, hormone therapy is not only effective — it is safe, and it meaningfully improves quality of life and long-term health. Every patient deserves a personalized discussion, not a one-size-fits-all answer."

At Haven OBGYN, menopause evaluation includes a full symptom review, bone density discussion, cardiovascular risk assessment, and a frank conversation about all available options — including hormone therapy (systemic and local), non-hormonal medications, lifestyle interventions, and supplements with supporting evidence. The goal is to help you navigate this phase with clarity, confidence, and the best possible quality of life.

Frequently Asked Questions

Common questions about menopause and perimenopause, answered by Dr. Nikita Mishra

For most healthy women under 60, or within 10 years of menopause onset, the benefits of hormone therapy (HT) outweigh the risks — particularly for managing vasomotor symptoms, preventing bone loss, and improving quality of life. The 2023 NAMS Hormone Therapy Position Statement and updated ACOG guidance confirm that earlier concerns from the Women's Health Initiative (2002) were overstated and applied to an older population. Modern hormone therapy — particularly transdermal estrogen with micronized progesterone — has a favorable safety profile. The decision is always individualized based on your symptoms, health history, and personal preferences.

Vasomotor symptoms (hot flashes and night sweats) last longer than was historically assumed. The SWAN study — a landmark longitudinal study of women through the menopause transition — found that median duration of frequent vasomotor symptoms was 7.4 years, with women who began symptoms in perimenopause experiencing them for the longest duration (up to 11+ years). Women who experience symptoms primarily after the final period tend to have a shorter duration. This underscores the importance of proactive symptom management rather than simply waiting for symptoms to pass.

Yes. Despite irregular cycles, ovulation can still occur during perimenopause, and pregnancy — while uncommon — is possible. ACOG recommends continuing contraception until menopause is confirmed (12 consecutive months without a period) or until age 55, whichever comes first. Notably, low-dose hormonal contraception during perimenopause can also help regulate irregular bleeding, reduce vasomotor symptoms, and protect bone density — making it a dual-purpose option for many women in this transition.

Yes, and it is well-documented. Research shows that the menopause transition is associated with changes in verbal memory, processing speed, and attention — particularly during perimenopause when hormone fluctuations are most erratic. The SWAN study demonstrated measurable cognitive changes during this period. Contributing factors include sleep disruption from night sweats, estrogen's direct role in cognitive function, and mood changes. For most women, cognitive symptoms improve after the menopause transition stabilizes. Hormone therapy may provide benefit for cognitive symptoms when initiated early in the menopause transition.

Several non-hormonal options have evidence supporting their use. Fezolinetant (Veozah) — an FDA-approved neurokinin 3 receptor antagonist — is a newer non-hormonal prescription medication for moderate-to-severe vasomotor symptoms with demonstrated efficacy in clinical trials. SSRIs and SNRIs (particularly paroxetine, escitalopram, and venlafaxine) have the strongest evidence among other non-hormonal options. Gabapentin has evidence particularly for night sweats. Cognitive behavioral therapy (CBT) has also shown meaningful reductions in the impact of hot flashes. Over-the-counter supplements like black cohosh have limited and inconsistent evidence and are not endorsed by ACOG as first-line.

Clinically reviewed by Nikita Mishra, MD, FACOG

Board-Certified OB-GYN & Minimally Invasive Gynecologic Surgeon
Haven OBGYN · Folsom, CA

Published: May 2026  ·  Last reviewed: May 2026

References

Understanding Menopause

Menopause Is a Transition — Not an Endpoint

You deserve evidence-based guidance, real options, and a provider who takes your symptoms seriously. Schedule at Haven OBGYN.

Request Appointment (916) 269-8865